Literature DB >> 24235949

Sonographic assessment of pregnancy co-existing with uterine leiomyoma in Owerri, Nigeria.

C U Eze1, E A Odumeru, K Ochie, U I Nwadike, K K Agwuna.   

Abstract

BACKGROUND: Uterine myomas co-existing with pregnancy could cause obstetric complications.
OBJECTIVES: To assess sonographically the frequency of occurrence and effect of uterine myomas co-existing with pregnancy.
METHODS: A longitudinal study was conducted during a period of 23 months. A convenience sample of 816 consecutive consenting pregnant women who met the inclusion criteria was evaluated during routine prenatal ultrasound scan. The women were referred for prenatal sonography. One hundred of the subjects who had myoma co-existing with pregnancy and another 100 subjects without myoma were selected for follow-up. These groups were followed up till delivery and obstetric complications and outcomes were documented. Any changes in size and growth rate of myoma were documented.
RESULTS: Subjects with myoma co-existing with pregnancy were 12.3%. This was commoner with increasing maternal age. An increase was observed in myoma mean size from 60mm to 63mm from the 1(st) scan sequence to the 2(nd) scan sequence and a reduction from 63mm to 59mm in the 3(rd) scan sequence. Myoma growth rate was 0.667mm per week. Myomas in pregnancy especially large ones caused more complications during delivery when compared to pregnancies without myomas.
CONCLUSION: Routine sonography is important in pregnancy management of uterine myomas co-existing with pregnancy.

Entities:  

Keywords:  Routine sonography; obstetric complications; pregnancy; uterine myoma

Mesh:

Year:  2013        PMID: 24235949      PMCID: PMC3824468          DOI: 10.4314/ahs.v13i2.36

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  23 in total

Review 1.  Fibroids and infertility: a systematic review of the evidence.

Authors:  E A Pritts
Journal:  Obstet Gynecol Surv       Date:  2001-08       Impact factor: 2.347

2.  A microscopic study of the growth of leiomyomas of the uterus during pregnancy.

Authors:  E J LAMB; R R GREENE
Journal:  Surg Gynecol Obstet       Date:  1959-05

3.  Progesterone therapy in uterine fibromyoma.

Authors:  A L GOODMAN
Journal:  J Clin Endocrinol Metab       Date:  1946-05       Impact factor: 5.958

4.  Evaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination, and diagnostic hysteroscopy.

Authors:  M Dueholm; E Lundorf; E S Hansen; S Ledertoug; F Olesen
Journal:  Fertil Steril       Date:  2001-08       Impact factor: 7.329

5.  Pregnancy-related changes in the size of uterine leiomyomas.

Authors:  Ran Neiger; Jiri D Sonek; Christopher S Croom; Gary Ventolini
Journal:  J Reprod Med       Date:  2006-09       Impact factor: 0.142

6.  Diet and uterine myomas.

Authors:  F Chiaffarino; F Parazzini; C La Vecchia; L Chatenoud; E Di Cintio; S Marsico
Journal:  Obstet Gynecol       Date:  1999-09       Impact factor: 7.661

7.  Large uterine leiomyomata and risk of cesarean delivery.

Authors:  Patrizia Vergani; Anna Locatelli; Alessandro Ghidini; Marianna Andreani; Francesca Sala; John C Pezzullo
Journal:  Obstet Gynecol       Date:  2007-02       Impact factor: 7.661

8.  [Significance of myoma-induced complications in pregnancy. A comparative analysis of pregnancy course with and without myoma involvement].

Authors:  B Aydeniz; D Wallwiener; C Kocer; E M Grischke; I J Diel; C Sohn; G Bastert
Journal:  Z Geburtshilfe Neonatol       Date:  1998 Jul-Aug       Impact factor: 0.685

9.  [Changes in uterine myoma dimentions during pregnancy].

Authors:  D Bosev; A Dimitrov
Journal:  Akush Ginekol (Sofiia)       Date:  2007

10.  [The incidence of uterine leiomyomas in pregnancy and their influence upon its course].

Authors:  Barbara Bałoniak; Zbigniew Słomko; Zbyszko Malewski; Krzysztof Drews
Journal:  Ginekol Pol       Date:  2002-04       Impact factor: 1.232

View more
  8 in total

1.  Nodding syndrome, infections and sexuality.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

2.  Natural history of fibroids in pregnancy: National Institute of Child Health and Human Development Fetal Growth Studies - Singletons cohort.

Authors:  Susanna D Mitro; Shyamal Peddada; Zhen Chen; Germaine M Buck Louis; Jessica L Gleason; Cuilin Zhang; Katherine L Grantz
Journal:  Fertil Steril       Date:  2022-08-16       Impact factor: 7.490

3.  The risk of preterm birth in women with uterine fibroids: A systematic review and meta-analysis.

Authors:  Anadeijda J E M C Landman; Emma E Don; Guus Vissers; Hans C J Ket; Martijn A Oudijk; Christianne J M de Groot; Judith A F Huirne; Marjon A de Boer
Journal:  PLoS One       Date:  2022-06-02       Impact factor: 3.752

4.  Ultrasonographic assessment of splenic volume at presentation and after anti-malarial therapy in children with malarial anaemia.

Authors:  Moses Laman; Susan Aipit; Cathy Bona; Peter M Siba; Leanne J Robinson; Laurens Manning; Timothy M E Davis
Journal:  Malar J       Date:  2015-05-28       Impact factor: 2.979

5.  Pregnancy outcomes in nulliparous women after ultrasound ablation of uterine fibroids: A single-central retrospective study.

Authors:  Jun Shu Li; Yong Wang; Jin Yun Chen; Wen Zhi Chen
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

6.  Does Uterine Fibroid Adversely Affect Obstetric Outcome of Pregnancy?

Authors:  Hend S Saleh; Hala E Mowafy; Azza A Abd El Hameid; Hala E Sherif; Eman M Mahfouz
Journal:  Biomed Res Int       Date:  2018-03-26       Impact factor: 3.411

7.  Epidemiology of uterine fibroid in black African women: a systematic scoping review.

Authors:  Imran O Morhason-Bello; Clement A Adebamowo
Journal:  BMJ Open       Date:  2022-08-03       Impact factor: 3.006

8.  Commentary on the article "Pre-treatment with ulipristal acetate before ICSI procedure: a case report" published in Menopause Review 6/2013 (Przegląd Menopauzalny 2013; 6: 496-500).

Authors:  Artur Wdowiak
Journal:  Prz Menopauzalny       Date:  2014-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.